Dermatology · Los Angeles, CA
NPI
1932270824
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6041 Cadillac Ave
Los Angeles, CA, 90034
Phone (323) 857-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,323
35 services
Medicare patients, 2024
15
Average age 66
Drug cost, 2024
$891K
1,553 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug David J Goldstein prescribed most often to Medicare patients was Clobetasol Propionate, with 218 prescriptions and refills. In total David J Goldstein wrote 1,553 Medicare prescriptions that cost $891K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clobetasol Propionate Generic | 218 | 226 | 122 | $4,899 |
| Ketoconazole Generic | 109 | 141 | 51 | $1,974 |
| Mometasone Furoate Generic | 93 | 109 | 60 | $3,826 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 67 | 78 | 47 | $1,685 |
| Zoryve Roflumilast | 66 | 66 | 49 | $69K |
| Retin-A Tretinoin | 56 | 59 | 35 | $1,499 |
| Fluocinonide Generic | 55 | 55 | 30 | $866 |
| Fluorouracil Generic | 52 | 52 | 45 | $2,010 |
| Hydrocortisone Generic | 52 | 54 | 29 | $815 |
| Clindamycin Phosphate Generic | 50 | 55 | 31 | $1,162 |
| Ciclopirox Ciclopirox Olamine | 43 | 48 | 20 | $938 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 41 | 71 | Under 11 | $297K |
| Selenium Sulfide Generic | 38 | 41 | 20 | $890 |
| Triamcinolone Acetonide Generic | 38 | 47 | 20 | $520 |
| Vtama Tapinarof | 31 | 31 | 16 | $43K |
Brand drugs: 352 claims; generic drugs: 1,201 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to David J Goldstein were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.